NephroSant Founder's Chancery Redaction Bid Is Rejected

By Rose Krebs · May 12, 2023, 4:29 PM EDT

A judicial officer has determined NephroSant Inc.'s former CEO should lose a bid to keep certain information confidential in Delaware Chancery Court litigation she filed seeking to have the kidney disease...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Recent Articles By Rose

April 18, 2024
Patient Data Breach Suit Should Be Tossed, Colo. Judge Says
March 05, 2024
Ex-Walgreens CLO Joins UnitedHealth In Advisory Role
February 28, 2024
WilmerHale Adds Ex-Medtronic Legal Leader To Its DC Office
January 16, 2024
McDermott Lands Healthcare Team From Wilson Sonsini
October 10, 2023
Feds, Atty Agree On Probation For Illegal $1.3M Share Sale
September 28, 2023
First Wave BioPharma Director Loses Legal Fee Battle In Del.
June 26, 2023
Walmart Investors Balk At Stay Request In Del. Opioid Suit
June 13, 2023
OptimisCorp Attys Want Out Of Arb. Award Row In Chancery
May 11, 2023
Fortis Rips J&J's Bid To DQ Selendy Gay In Chancery Case
January 30, 2023
First Wave BioPharma Director Sues For Legal Fees In Del.